Precipio, Inc. (NASDAQ:PRPO)

Friday, February 20, 2026, 8:30 AM
Precipio, Inc. (PRPO): A Microcap stealing Market Share from Industry Giants and Nearing an Earnings Inflection
See All Articles and Reports...
Sunday, February 22, 2026, 3:32 PM
Why “Not Being Wrong” Beats Being Right: A Skull Session with Carlos Morales, Quant Investor [GeoWire Weekly No. 227] | Healthcare Stock with 100% Upside
Sunday, November 30, 2025, 2:27 PM
Q3 Favorite Earnings Reports Review with Sebastian Krog [GeoWire Weekly No. 215] | REOP ITRN SMTI BURCA ACFN MG PRPO MUEL DBO.TO WOLF.V CTEK.V URL.CN
See All GeoWire Weekly...
Precipio is a healthcare biotechnology company focused on cancer diagnostics. Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form of diagnostic products and services. Our products and services deliver higher accuracy, improved laboratory workflow, and ultimately better patient outcomes, which reduce healthcare expenses. Precipio develops innovative technologies in our laboratory where we design, test, validate, and use these products clinically, improving diagnostic outcomes. Precipio then commercializes these technologies as proprietary products that serve the global laboratory community and further scales Precipio's reach to eradicate misdiagnosis.

Web site: http://www.precipiodx.com/

Last updated February 14, 2026


Market Data powered by QuoteMedia. Terms of Use